Robust Hotels (RHL)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 53% discount to book value: price ₹189.90 vs book value ₹407.62, P/B of 0.47.
• Conservative capital structure with debt/equity of only 0.21.
• Piotroski F-score of 7/9 indicates improving financial health.
• Promoter holding of 65.63% aligns management with minority shareholders.
• Revenue growth of 17.75% and profit growth of 179.84% signal a cyclical recovery underway.

Concerns

• Low profitability: ROE of 4.44% and ROCE of 5.12% show weak earnings power relative to capital employed.
• No dividend yield; shareholders depend entirely on price appreciation and asset re-rating.
• Profit growth of 179.84% comes off a small base and may not be sustainable; latest quarter net profit is only ₹7 Cr on sales of ₹39 Cr.
• Price remains well below the 52-week high of ₹309.90, suggesting market skepticism or continued sector weakness.

AI Analysis

Robust Hotels presents the kind of balance-sheet first puzzle I enjoy. The stock trades at ₹189.90 with book value of ₹407.62, so the market is pricing only 47 paise per rupee of net worth. That is a genuine Graham-style margin of safety, provided the assets are productive and management is honest. With 65.63% promoter holding, owners are deeply invested. Debt/equity of 0.21 is conservative, so I don't lose sleep over near-term solvency. But a cheap balance sheet is not a wonderful business. Return on equity is exactly 4.44% and return on capital employed is only 5.12% — far below what a shareholder could earn elsewhere. This hotel enterprise is earning a poor return on a large asset base. The 179.84% profit growth and 17.75% sales growth look impressive, but they come off a low base. Latest quarter sales of ₹39 Cr and net profit of ₹7 Cr imply trailing earnings around ₹27 Cr, giving a P/E of 12.3. The Piotroski F-score of 7 suggests fundamentals are improving, and the low PEG of 0.12 is tempting. Yet I must be wary: in cyclical hospitality, one good quarter can be followed by another weak one. P/E and PEG can mislead when earnings are recovering. The clean balance sheet and half-price book value make this an asset play, but not yet a compounder. I would want several years of rising return on equity and consistent cash generation before assigning it a 'wonderful business' label. At this price, it is an interesting bargain candidate, not a certainty.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer